Pharmacokinetic properties and bioequivalence of two formulations of arbidol: An open-label, single-dose, randomized-sequence, two-period crossover study in healthy chinese male volunteers

Background: Arbidol is an antiviral drug indicated for the prevention and treatment of all types of influenza infection and some other kinds of acute respiratory infections, specifically against influenza groups A and B, and severe acute respiratory syndrome. It is used to help prevent influenza inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ming-Yan, Wang, Shuang, Yao, Wei-Fan, Wu, Hui-zhe, Meng, Sheng-Nan, Wei, Min-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133634/
https://www.ncbi.nlm.nih.gov/pubmed/19446151
http://dx.doi.org/10.1016/j.clinthera.2009.04.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133634/
https://www.ncbi.nlm.nih.gov/pubmed/19446151
http://dx.doi.org/10.1016/j.clinthera.2009.04.016

Ejemplares similares